Short Interest in CellaVision AB (publ) (OTCMKTS:CLVSF) Drops By 50.6%

CellaVision AB (publ) (OTCMKTS:CLVSF) was the recipient of a significant decrease in short interest in February. As of February 13th, there was short interest totaling 1,045 shares, a decrease of 50.6% from the January 29th total of 2,116 shares. Based on an average daily trading volume, of 112 shares, the short-interest ratio is presently 9.3 days. Based on an average daily trading volume, of 112 shares, the short-interest ratio is presently 9.3 days.

CellaVision AB (publ) Stock Performance

CLVSF remained flat at $15.85 on Friday. The business has a fifty day moving average price of $16.64 and a 200-day moving average price of $17.84. CellaVision AB has a twelve month low of $16.69 and a twelve month high of $17.30.

About CellaVision AB (publ)

CellaVision AB (publ), headquartered in Lund, Sweden, is a developer and manufacturer of advanced digital cell morphology solutions for clinical laboratories. The company’s systems automate the preparation, imaging and classification of blood and body fluid slides, enabling laboratory professionals to optimize workflow and improve diagnostic accuracy. CellaVision’s platform is designed to support a broad range of hematology analyses, including white blood cell differentiation, red blood cell morphology assessment and platelet evaluation.

The company’s core offering revolves around its digital microscopy instruments and proprietary software.